Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-06T01:54:46.257Z Has data issue: false hasContentIssue false

Impact of atrial septal defect device size on biventricular global and regional function: a two-dimensional strain echocardiographic study

Published online by Cambridge University Press:  05 August 2021

Areej Alkhateeb*
Affiliation:
Cardiology Division of Internal Medicine Department, South Valley University Hospital, Qena, 83523 Egypt
Alaa Roushdy
Affiliation:
Congenital and Structural Heart Disease Unit, Cardiology Department – Ain Shams University Hospitals, Cairo, 11566 Egypt
Hosam Hasan-Ali
Affiliation:
Department of Cardiology, Assiut University Hospitals, Assiut, 71515 Egypt
Yehia T. Kishk
Affiliation:
Department of Cardiology, Assiut University Hospitals, Assiut, 71515 Egypt
Aya El Sayegh
Affiliation:
Congenital and Structural Heart Disease Unit, Cardiology Department – Ain Shams University Hospitals, Cairo, 11566 Egypt
Ayman K.M. Hassan
Affiliation:
Department of Cardiology, Assiut University Hospitals, Assiut, 71515 Egypt
*
Author for correspondence: Areej A.A.Tammam Alkhateeb, CVR Msc (KCL, UK), MD, PhD, Cardiology Division of Internal Medicine Department, South Valley University Hospital, 83523 Qena, Egypt. Mobile: (+20) 1023858689. E-mail: areejalkhateeb@med.svu.edu.eg
Rights & Permissions [Opens in a new window]

Abstract

Objective:

In this study, we assessed the acute changes in biventricular longitudinal strain after atrial septal defect transcatheter closure and its relation to the device size.

Methods:

Hundred atrial septal defect patients and 40 age-matched controls were included. Echocardiography and strain study were performed at baseline and 24 hours and 1 month after the intervention. The study group was divided into two subgroups; group 1: smaller devices were used (mean device size = 1.61 ± 0.05 cm, n = 74) and group 2: larger devices were used (mean device size = 2.95 ± 0.07 cm, n = 26).

Results:

At baseline, there was a significant difference between the study group and controls as regards right ventricular global longitudinal strain with significant hyperkinetic apex (p = 0.033, p = 0.020, respectively). There was a significant immediate reduction in right ventricular global longitudinal strain (from −24.43 ± 0.49% to −21.62 ± 0.47%, p < 0.001), which showed insignificant improvement after 1-month follow-up. While only left ventricular global longitudinal strain increased after 1 month. Within 24 hours of device closure, all the basal- and mid-lateral segments strains and apical right ventricular strains showed a significant reduction. There was a significant negative correlation between the indexed large device size and an immediate change in the right ventricular global longitudinal strain (r = −0.425, p = 0.034).

Conclusion:

Significant right ventricular global longitudinal strain reduction starts as early as 24 hours after transcatheter closure, irrespective of the device size used. The rapid impact of closure was mainly on the biventricular basal and lateral segments and right ventricular apical ones, especially with the large sized atrial septal defect.

Information

Type
Original Article
Copyright
© The Author(s), 2021. Published by Cambridge University Press
Figure 0

Figure 1. Two-dimensional transthoracic echocardiographic apical four-chamber view of left and right ventricular global and segmental longitudinal systolic strain changes of one case of atrial septal defect before, 24 hours, and 1 month after atrial septal defect device closure: A. Left ventricular AP4L strain before closure (−20.5%). B. Left ventricular -AP4L strains 24 hours after closure (−19.4%). C. Left ventricular AP4L strains 1 month after closure (−25.8%). D. Right ventricular AP4L strains before closure (−33.4%). E. Right ventricular AP4L strains 24 hours after closure (−32.4%). F. Right ventricular AP4L strains 1 month after closure (−29.6%). Abbreviations: ASD = atrial septal defect; LV = left ventricle; RV = right ventricle; AP4L = apical four-chamber longitudinal strain; GLS = global longitudinal strain.

Figure 1

Table 1. Demographic characteristics of the ASD versus control groups

Figure 2

Table 2. Baseline transthoracic echocardiographic measures of ASD versus control groups

Figure 3

Table 3. Baseline two-dimensional transthoracic echocardiographic biventricular longitudinal regional systolic strains of ASD and control groups

Figure 4

Table 4. Baseline standard transthoracic echocardiographic measures of ASD before, 24 hours, and 1 month after device closure

Figure 5

Table 5. Two-dimensional transthoracic echocardiographic left and right ventricular longitudinal regional systolic strains of the ASD group at baseline, 24 hours, and 1 month after device closure

Figure 6

Figure 2. The comparative changes in biventricular longitudinal regional strains before, 24 hours, and 1 month after atrial septal defect device closure. A. Linear chart of the changes in apical left ventricular strain versus basal-septal one. B. Linear chart of the changes in apical left ventricular strain versus basal-lateral one. C. Linear chart of the changes in mid-lateral left ventricular strain versus mid-septal one. D. Linear chart of the changes in basal-lateral left ventricular strain versus basal-septal one. E. Linear chart of the changes in apical right ventricular strain versus basal-septal one. F. Linear chart of the changes in apical right ventricular strain versus basal-lateral one. G. Linear chart of the changes in mid-lateral right ventricular strain versus mid-septal one. H. Linear chart of the changes in basal-lateral right ventricular strain versus basal-septal one. Reported data were expressed as mean values ±SEM. Significant P-value < 0.05. *Significant P-value. **Significant P-value (< 0.001). Statistical analysis of each segment was done by paired two-tailed t-test. Abbreviations: RV = right ventricle; LV = left ventricle; PLSS = peak longitudinal systolic strain.

Figure 7

Table 6. Correlation table between the delta change of the biventricular global longitudinal strain perioperatively and the device size and indexed device size of total versus large versus small device groups

Figure 8

Figure 3. The correlation charts between the device size indexed to body surface area and delta change in right ventricular global longitudinal strain after 24 hours of atrial septal defect device closure and 95% confidence interval. Significant negative weak correlation between the indexed device size/body surface area and delta 1 change in right ventricular global longitudinal strain of the large atrial septal defect study subgroup (r: −0.425, p = 0.034). The higher range of indexed large device size to small body surface area (>3 cm/m2) had a lower degree in right ventricular global longitudinal strain acute reduction to normal value than that of low- to mid-range size of indexed large device size (between 1.5–3 cm/m2). Abbreviations: Delta 1: difference between 24-hour post-atrial septal defect device closure and before closure. RVGLS = right ventricular global longitudinal systolic strain; BSA = body surface area. Significant P-value < 0.05. Statistical analysis was done by bivariate correlation (R).